Patient and Public Engagement in the development of cell and gene therapies – why it matters and how to engage with people

Involving patients in the development of ATMPs is a key part of improving outcomes for patients. This webinar explores the rationale around why patient and public engagement is essential in the development of new therapies, focusing on the specific challenges and needs for cell and gene therapy and the benefits to patient and clinical outcomes when this work is done…

Ask the experts: cancer - Prof Fiona Thistlethwaite

Ask the experts: liver disease and rheumatoid arthritis - Andrew Filer/Sheeba Khan

Introducing cell and gene therapies - Dr Ceri Roberts

Patient and Public Perspectives on Cell and Gene Therapies - Dr Lee Aiyegbusi